Melphalan 140mg/m2 or 200mg/m2 for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party - Auner, HW; Iacobelli, S; Sbianchi, G; Knol-Bout, C; Blaise, D; Russell, NH; Apperley, JF; Pohlreich, D; Browne, P; Kobbe, G; Isaksson, C; Lenhoff, S; et al. (Haematologica, 2017)